Breast Cancer

AACR: LY2835219 promising for metastatic breast cancer

(HealthDay)—The novel cell cycle inhibitor selective for the cyclin-dependent kinases CDK4 and CDK6 (CDK4/6), LY2835219, shows promise for metastatic breast cancer, according to a study presented at the ...

Apr 07, 2014
popularity not rated yet | comments 0

Tissue testing during breast cancer lumpectomies

Unique laboratory testing during breast cancer lumpectomies to make sure surgeons remove all cancerous tissue spares patients the need for a repeat lumpectomy in roughly 96 percent of cases at Mayo Clinic ...

Apr 07, 2014
popularity not rated yet | comments 0

Latest Spotlight News